Holm-Jorgensen Rasmus has filed 10 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 109309 shares of Acrivon Therapeutics, Inc. ($ACRV) on March 01, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2025 | Acrivon Therapeutics, Inc. | $ACRV | Holm-Jorgensen Rasmus | Chief Financial Officer | A | Stock Option (Right to Buy) | 109309 | $0.00 | 109,309.0000 | 33,791,817 | 9999.99% | 0.32% |
| Feb. 14, 2025 | Acrivon Therapeutics, Inc. | $ACRV | Holm-Jorgensen Rasmus | Chief Financial Officer | F | Common Stock | 434 | $5.42 | 26,088.0000 | 33,791,817 | 1.64% | 0.00% |
| March 1, 2024 | Acrivon Therapeutics, Inc. | $ACRV | Holm-Jorgensen Rasmus | Chief Financial Officer | A | Stock Option (Right to Buy) | 90090 | $0.00 | 90,090.0000 | 22,078,190 | 9999.99% | 0.41% |
| Nov. 14, 2024 | Acrivon Therapeutics, Inc. | $ACRV | Holm-Jorgensen Rasmus | Chief Financial Officer | F | Common Stock | 368 | $7.92 | 26,522.0000 | 38,105,131 | 1.37% | 0.00% |
| Aug. 14, 2024 | Acrivon Therapeutics, Inc. | $ACRV | Holm-Jorgensen Rasmus | Chief Financial Officer | F | Common Stock | 368 | $7.02 | 26,890.0000 | 22,078,190 | 1.35% | 0.00% |
| May 14, 2024 | Acrivon Therapeutics, Inc. | $ACRV | Holm-Jorgensen Rasmus | Chief Financial Officer | F | Common Stock | 368 | $8.36 | 27,258.0000 | 22,078,190 | 1.33% | 0.00% |
| Feb. 14, 2024 | Acrivon Therapeutics, Inc. | $ACRV | Holm-Jorgensen Rasmus | Chief Financial Officer | F | Common Stock | 434 | $3.40 | 27,626.0000 | 22,078,190 | 1.55% | 0.00% |
| Nov. 14, 2023 | Acrivon Therapeutics, Inc. | $ACRV | Holm-Jorgensen Rasmus | Chief Financial Officer | F | Common Stock | 1470 | $5.08 | 28,060.0000 | 0 | 4.98% | 0.00% |
| June 16, 2023 | Acrivon Therapeutics, Inc. | $ACRV | Holm-Jorgensen Rasmus | Chief Financial Officer | M | Common Stock | 9500 | $3.63 | 29,530.0000 | 0 | 47.43% | 0.00% |
| June 16, 2023 | Acrivon Therapeutics, Inc. | $ACRV | Holm-Jorgensen Rasmus | Chief Financial Officer | M | Stock Option (Right to Buy) | 9500 | $0.00 | 183,119.0000 | 0 | 4.93% | 0.00% |